返回 Agenda
Session 3: Turning fundamental research into innovative treatments
Session Chair(s)
Greg Jordinson, MSC
Policy Liaison
Johnson & Johnson, United Kingdom
Session 3: Turning fundamental research into innovative treatments
Speaker(s)
“The Value of the Innovation” – PhRMA Report
Greg Jordinson, MSC
Johnson & Johnson, United Kingdom
Policy Liaison
Patients Driving Innovation
Mathieu Boudes, PHD
Montsouris Consilium, France
Patient Engagement Director
The use of Real World Data in Regulatory Decision
Gracy G Crane, PHD, MS
Roche, United Kingdom
Policy Lead